Pevonedistat, a Neuronal Precursor Cell‐Expressed Developmentally Down‐Regulated Protein 8–Activating Enzyme Inhibitor, Is a Potent Inhibitor of Hepatitis B Virus

Hepatology ◽  
2019 ◽  
Vol 69 (5) ◽  
pp. 1903-1915 ◽  
Author(s):  
Kazuma Sekiba ◽  
Motoyuki Otsuka ◽  
Motoko Ohno ◽  
Mari Yamagami ◽  
Takahiro Kishikawa ◽  
...  
Keyword(s):  
Hepatitis B Virus ◽  
Hepatitis B ◽  
Potent Inhibitor ◽  
Enzyme Inhibitor ◽  
Precursor Cell ◽  
Neuronal Precursor ◽  
B Virus ◽  
Neuronal Precursor Cell

scholarly journals 402 – Pevonedistat, a First-In-Class Nedd8-Activating Enzyme Inhibitor, is a Potent Inhibitor of Hepatitis B Virus

2019 ◽  
Vol 156 (6) ◽  
pp. S-1194
Author(s):  
Kazuma Sekiba ◽  
Motoyuki Otsuka ◽  
Kazuhiko Ko
Keyword(s):  
Hepatitis B Virus ◽  
Hepatitis B ◽  
Potent Inhibitor ◽  
Enzyme Inhibitor ◽  
B Virus

Intracellular Metabolism of β-L-ddAMP-bis(tbutylSATE), a Potent Inhibitor of Hepatitis B Virus Replication

1999 ◽  
Vol 18 (4-5) ◽  
pp. 987-988 ◽  
Author(s):  
A. Faraj ◽  
L. Placidi ◽  
C. Perigaud ◽  
E. Cretton-scott ◽  
G. Gosselin ◽  
...  
Keyword(s):  
Hepatitis B Virus ◽  
Hepatitis B ◽  
Virus Replication ◽  
Potent Inhibitor ◽  
B Virus ◽  
Intracellular Metabolism

Ganciclovir is a potent inhibitor of duck hepatitis B virus replication in vivo

1991 ◽  
Vol 15 ◽  
pp. 131
Author(s):  
Tim Shaw ◽  
Scott Bowden ◽  
Yanyan Wang ◽  
Gilda Civitico ◽  
Stephen Locarnini
Keyword(s):  
Hepatitis B Virus ◽  
Hepatitis B ◽  
Virus Replication ◽  
Potent Inhibitor ◽  
Duck Hepatitis B Virus ◽  
Duck Hepatitis ◽  
B Virus

Irbesartan, an FDA approved drug for hypertension and diabetic nephropathy, is a potent inhibitor for hepatitis B virus entry by disturbing Na+-dependent taurocholate cotransporting polypeptide activity

2015 ◽  
Vol 120 ◽  
pp. 140-146 ◽  
Author(s):  
Xue-jun Wang ◽  
Wei Hu ◽  
Ting-yu Zhang ◽  
Ying-ying Mao ◽  
Nan-nan Liu ◽  
...  
Keyword(s):  
Diabetic Nephropathy ◽  
Hepatitis B Virus ◽  
Hepatitis B ◽  
Potent Inhibitor ◽  
Virus Entry ◽  
B Virus

scholarly journals Pharmacokinetics studies of 4′-cyano-2′-deoxyguanosine, a potent inhibitor of the hepatitis B virus, in rats

2018 ◽  
Vol 70 (6) ◽  
pp. 723-731 ◽  
Author(s):  
Mai Hashimoto ◽  
Kazuaki Taguchi ◽  
Takako Ishiguro ◽  
Satoru Kohgo ◽  
Shuhei Imoto ◽  
...  
Keyword(s):  
Hepatitis B Virus ◽  
Hepatitis B ◽  
Potent Inhibitor ◽  
B Virus
Sign in / Sign up

Export Citation Format

Share Document